nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—DDC—Dopamine metabolism—TYR—melanoma	0.0786	0.313	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—CDKN1C—melanoma	0.0272	0.108	CbGpPWpGaD
Carbidopa—DDC—Amine-derived hormones—SLC5A5—melanoma	0.0164	0.0655	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—APAF1—melanoma	0.0116	0.0462	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—POU3F2—melanoma	0.00959	0.0382	CbGpPWpGaD
Carbidopa—Isoprenaline—MAPK1—melanoma	0.00938	0.527	CrCbGaD
Carbidopa—DDC—Circadian rythm related genes—RAI1—melanoma	0.00879	0.035	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP1B1—melanoma	0.00654	0.0261	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—MAP2—melanoma	0.00551	0.022	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—ARNT—melanoma	0.00523	0.0208	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PAX4—melanoma	0.00505	0.0201	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—SLC6A11—melanoma	0.00501	0.02	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—MTAP—melanoma	0.00487	0.0194	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—TP73—melanoma	0.00469	0.0187	CbGpPWpGaD
Carbidopa—Mesalazine—PPARG—melanoma	0.00435	0.245	CrCbGaD
Carbidopa—DDC—Amino acid and derivative metabolism—PHGDH—melanoma	0.00434	0.0173	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—STAT3—melanoma	0.00324	0.0129	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP3—melanoma	0.00319	0.0127	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—MDM2—melanoma	0.00306	0.0122	CbGpPWpGaD
Carbidopa—Constipation—Vemurafenib—melanoma	0.00299	0.00408	CcSEcCtD
Carbidopa—Haemorrhage—Bleomycin—melanoma	0.00298	0.00407	CcSEcCtD
Carbidopa—Hypoaesthesia—Bleomycin—melanoma	0.00296	0.00405	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Temozolomide—melanoma	0.00292	0.00399	CcSEcCtD
Carbidopa—Pollakiuria—Temozolomide—melanoma	0.0029	0.00397	CcSEcCtD
Carbidopa—Depression—Carmustine—melanoma	0.00289	0.00395	CcSEcCtD
Carbidopa—Agranulocytosis—Dactinomycin—melanoma	0.00289	0.00395	CcSEcCtD
Carbidopa—Weight increased—Temozolomide—melanoma	0.00286	0.00391	CcSEcCtD
Carbidopa—Weight decreased—Temozolomide—melanoma	0.00284	0.00388	CcSEcCtD
Carbidopa—Neuropathy peripheral—Carmustine—melanoma	0.00284	0.00388	CcSEcCtD
Carbidopa—Urinary tract infection—Carmustine—melanoma	0.00281	0.00385	CcSEcCtD
Carbidopa—Phlebitis—Docetaxel—melanoma	0.0028	0.00383	CcSEcCtD
Carbidopa—Depression—Temozolomide—melanoma	0.00279	0.00382	CcSEcCtD
Carbidopa—Flushing—Bleomycin—melanoma	0.00276	0.00378	CcSEcCtD
Carbidopa—Body temperature increased—Vemurafenib—melanoma	0.00276	0.00378	CcSEcCtD
Carbidopa—Neuropathy peripheral—Temozolomide—melanoma	0.00274	0.00375	CcSEcCtD
Carbidopa—Urinary tract infection—Temozolomide—melanoma	0.00272	0.00372	CcSEcCtD
Carbidopa—Alopecia—Bleomycin—melanoma	0.00263	0.0036	CcSEcCtD
Carbidopa—Haemoglobin—Carmustine—melanoma	0.00261	0.00357	CcSEcCtD
Carbidopa—Haemorrhage—Carmustine—melanoma	0.0026	0.00356	CcSEcCtD
Carbidopa—Hallucination—Carmustine—melanoma	0.00259	0.00354	CcSEcCtD
Carbidopa—Hypoaesthesia—Carmustine—melanoma	0.00259	0.00354	CcSEcCtD
Carbidopa—Hot flush—Docetaxel—melanoma	0.00258	0.00353	CcSEcCtD
Carbidopa—Flushing—Dactinomycin—melanoma	0.00258	0.00353	CcSEcCtD
Carbidopa—Hypersensitivity—Vemurafenib—melanoma	0.00257	0.00352	CcSEcCtD
Carbidopa—Menopausal symptoms—Docetaxel—melanoma	0.00256	0.0035	CcSEcCtD
Carbidopa—Dermatitis bullous—Docetaxel—melanoma	0.00253	0.00346	CcSEcCtD
Carbidopa—Haemoglobin—Temozolomide—melanoma	0.00253	0.00345	CcSEcCtD
Carbidopa—Haemorrhage—Temozolomide—melanoma	0.00251	0.00344	CcSEcCtD
Carbidopa—Asthenia—Vemurafenib—melanoma	0.00251	0.00343	CcSEcCtD
Carbidopa—Hypoaesthesia—Temozolomide—melanoma	0.0025	0.00342	CcSEcCtD
Carbidopa—Hallucination—Temozolomide—melanoma	0.0025	0.00342	CcSEcCtD
Carbidopa—Urinary tract disorder—Temozolomide—melanoma	0.00248	0.00339	CcSEcCtD
Carbidopa—Pruritus—Vemurafenib—melanoma	0.00247	0.00338	CcSEcCtD
Carbidopa—Urethral disorder—Temozolomide—melanoma	0.00246	0.00337	CcSEcCtD
Carbidopa—Alopecia—Dactinomycin—melanoma	0.00245	0.00336	CcSEcCtD
Carbidopa—Hyponatraemia—Docetaxel—melanoma	0.00242	0.00332	CcSEcCtD
Carbidopa—Pain in extremity—Docetaxel—melanoma	0.00242	0.0033	CcSEcCtD
Carbidopa—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00242	0.0033	CcSEcCtD
Carbidopa—Flushing—Carmustine—melanoma	0.00241	0.0033	CcSEcCtD
Carbidopa—Ill-defined disorder—Bleomycin—melanoma	0.00241	0.00329	CcSEcCtD
Carbidopa—Anaemia—Bleomycin—melanoma	0.0024	0.00328	CcSEcCtD
Carbidopa—Diarrhoea—Vemurafenib—melanoma	0.00239	0.00327	CcSEcCtD
Carbidopa—Malaise—Bleomycin—melanoma	0.00234	0.0032	CcSEcCtD
Carbidopa—Flushing—Temozolomide—melanoma	0.00233	0.00319	CcSEcCtD
Carbidopa—Leukopenia—Bleomycin—melanoma	0.00232	0.00317	CcSEcCtD
Carbidopa—Dizziness—Vemurafenib—melanoma	0.00231	0.00316	CcSEcCtD
Carbidopa—Alopecia—Carmustine—melanoma	0.0023	0.00314	CcSEcCtD
Carbidopa—DDC—Amino acid and derivative metabolism—SLC5A5—melanoma	0.00229	0.00912	CbGpPWpGaD
Carbidopa—Mental disorder—Carmustine—melanoma	0.00228	0.00311	CcSEcCtD
Carbidopa—Ataxia—Docetaxel—melanoma	0.00227	0.00311	CcSEcCtD
Carbidopa—Cough—Bleomycin—melanoma	0.00226	0.00309	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—GNA11—melanoma	0.00225	0.00898	CbGpPWpGaD
Carbidopa—Ill-defined disorder—Dactinomycin—melanoma	0.00224	0.00307	CcSEcCtD
Carbidopa—Anaemia—Dactinomycin—melanoma	0.00223	0.00306	CcSEcCtD
Carbidopa—Epinephrine—TNF—melanoma	0.00223	0.125	CrCbGaD
Carbidopa—Vomiting—Vemurafenib—melanoma	0.00222	0.00304	CcSEcCtD
Carbidopa—Alopecia—Temozolomide—melanoma	0.00222	0.00304	CcSEcCtD
Carbidopa—Chest pain—Bleomycin—melanoma	0.00221	0.00302	CcSEcCtD
Carbidopa—Orthostatic hypotension—Docetaxel—melanoma	0.00221	0.00302	CcSEcCtD
Carbidopa—Rash—Vemurafenib—melanoma	0.0022	0.00301	CcSEcCtD
Carbidopa—Mental disorder—Temozolomide—melanoma	0.0022	0.00301	CcSEcCtD
Carbidopa—Dermatitis—Vemurafenib—melanoma	0.0022	0.00301	CcSEcCtD
Carbidopa—Back pain—Carmustine—melanoma	0.00219	0.00299	CcSEcCtD
Carbidopa—Headache—Vemurafenib—melanoma	0.00219	0.00299	CcSEcCtD
Carbidopa—Discomfort—Bleomycin—melanoma	0.00218	0.00298	CcSEcCtD
Carbidopa—Malaise—Dactinomycin—melanoma	0.00218	0.00298	CcSEcCtD
Carbidopa—Cramp muscle—Docetaxel—melanoma	0.00217	0.00297	CcSEcCtD
Carbidopa—Leukopenia—Dactinomycin—melanoma	0.00216	0.00296	CcSEcCtD
Carbidopa—Nasopharyngitis—Docetaxel—melanoma	0.00216	0.00295	CcSEcCtD
Carbidopa—Dysgeusia—Temozolomide—melanoma	0.00214	0.00293	CcSEcCtD
Carbidopa—Confusional state—Bleomycin—melanoma	0.00213	0.00292	CcSEcCtD
Carbidopa—Vision blurred—Carmustine—melanoma	0.00213	0.00292	CcSEcCtD
Carbidopa—Tremor—Carmustine—melanoma	0.00212	0.0029	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—HDAC2—melanoma	0.00212	0.00845	CbGpPWpGaD
Carbidopa—Oedema—Bleomycin—melanoma	0.00212	0.00289	CcSEcCtD
Carbidopa—Back pain—Temozolomide—melanoma	0.00212	0.00289	CcSEcCtD
Carbidopa—Infection—Bleomycin—melanoma	0.0021	0.00287	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—GNAQ—melanoma	0.0021	0.00835	CbGpPWpGaD
Carbidopa—Anaemia—Carmustine—melanoma	0.00209	0.00286	CcSEcCtD
Carbidopa—Dysphagia—Docetaxel—melanoma	0.00209	0.00285	CcSEcCtD
Carbidopa—Agitation—Carmustine—melanoma	0.00208	0.00284	CcSEcCtD
Carbidopa—Nausea—Vemurafenib—melanoma	0.00207	0.00284	CcSEcCtD
Carbidopa—Thrombocytopenia—Bleomycin—melanoma	0.00207	0.00283	CcSEcCtD
Carbidopa—Vision blurred—Temozolomide—melanoma	0.00206	0.00282	CcSEcCtD
Carbidopa—Tremor—Temozolomide—melanoma	0.00205	0.0028	CcSEcCtD
Carbidopa—Discomfort—Dactinomycin—melanoma	0.00203	0.00278	CcSEcCtD
Carbidopa—Ill-defined disorder—Temozolomide—melanoma	0.00203	0.00277	CcSEcCtD
Carbidopa—Leukopenia—Carmustine—melanoma	0.00203	0.00277	CcSEcCtD
Carbidopa—Anaemia—Temozolomide—melanoma	0.00202	0.00276	CcSEcCtD
Carbidopa—Anorexia—Bleomycin—melanoma	0.00202	0.00276	CcSEcCtD
Carbidopa—Agitation—Temozolomide—melanoma	0.00201	0.00275	CcSEcCtD
Carbidopa—Angioedema—Temozolomide—melanoma	0.002	0.00273	CcSEcCtD
Carbidopa—Hypotension—Bleomycin—melanoma	0.00198	0.0027	CcSEcCtD
Carbidopa—Oedema—Dactinomycin—melanoma	0.00197	0.0027	CcSEcCtD
Carbidopa—Malaise—Temozolomide—melanoma	0.00197	0.0027	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL10—melanoma	0.00197	0.00784	CbGpPWpGaD
Carbidopa—Convulsion—Carmustine—melanoma	0.00196	0.00268	CcSEcCtD
Carbidopa—Infection—Dactinomycin—melanoma	0.00196	0.00268	CcSEcCtD
Carbidopa—Leukopenia—Temozolomide—melanoma	0.00196	0.00268	CcSEcCtD
Carbidopa—Hypertension—Carmustine—melanoma	0.00195	0.00267	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—NGFR—melanoma	0.00193	0.00771	CbGpPWpGaD
Carbidopa—Palpitations—Temozolomide—melanoma	0.00193	0.00264	CcSEcCtD
Carbidopa—Thrombocytopenia—Dactinomycin—melanoma	0.00193	0.00264	CcSEcCtD
Carbidopa—Chest pain—Carmustine—melanoma	0.00193	0.00263	CcSEcCtD
Carbidopa—Anxiety—Carmustine—melanoma	0.00192	0.00263	CcSEcCtD
Carbidopa—Cough—Temozolomide—melanoma	0.00191	0.00261	CcSEcCtD
Carbidopa—Paraesthesia—Bleomycin—melanoma	0.0019	0.0026	CcSEcCtD
Carbidopa—Weight increased—Docetaxel—melanoma	0.0019	0.0026	CcSEcCtD
Carbidopa—Convulsion—Temozolomide—melanoma	0.00189	0.00259	CcSEcCtD
Carbidopa—Weight decreased—Docetaxel—melanoma	0.00189	0.00258	CcSEcCtD
Carbidopa—Hypertension—Temozolomide—melanoma	0.00189	0.00258	CcSEcCtD
Carbidopa—Dyspnoea—Bleomycin—melanoma	0.00189	0.00258	CcSEcCtD
Carbidopa—Anorexia—Dactinomycin—melanoma	0.00188	0.00257	CcSEcCtD
Carbidopa—Confusional state—Carmustine—melanoma	0.00186	0.00255	CcSEcCtD
Carbidopa—Anxiety—Temozolomide—melanoma	0.00186	0.00254	CcSEcCtD
Carbidopa—Oedema—Carmustine—melanoma	0.00185	0.00253	CcSEcCtD
Carbidopa—Discomfort—Temozolomide—melanoma	0.00184	0.00252	CcSEcCtD
Carbidopa—Decreased appetite—Bleomycin—melanoma	0.00184	0.00252	CcSEcCtD
Carbidopa—Mesalazine—PTGS2—melanoma	0.00184	0.103	CrCbGaD
Carbidopa—Infection—Carmustine—melanoma	0.00183	0.00251	CcSEcCtD
Carbidopa—Acute coronary syndrome—Docetaxel—melanoma	0.00183	0.00251	CcSEcCtD
Carbidopa—Myocardial infarction—Docetaxel—melanoma	0.00182	0.00249	CcSEcCtD
Carbidopa—Neuropathy peripheral—Docetaxel—melanoma	0.00182	0.00249	CcSEcCtD
Carbidopa—Dry mouth—Temozolomide—melanoma	0.00182	0.00249	CcSEcCtD
Carbidopa—Pain—Bleomycin—melanoma	0.00181	0.00247	CcSEcCtD
Carbidopa—Thrombocytopenia—Carmustine—melanoma	0.00181	0.00247	CcSEcCtD
Carbidopa—Confusional state—Temozolomide—melanoma	0.0018	0.00246	CcSEcCtD
Carbidopa—Oedema—Temozolomide—melanoma	0.00178	0.00244	CcSEcCtD
Carbidopa—Infection—Temozolomide—melanoma	0.00177	0.00242	CcSEcCtD
Carbidopa—Anorexia—Carmustine—melanoma	0.00176	0.00241	CcSEcCtD
Carbidopa—Thrombocytopenia—Temozolomide—melanoma	0.00175	0.00239	CcSEcCtD
Carbidopa—Feeling abnormal—Bleomycin—melanoma	0.00174	0.00238	CcSEcCtD
Carbidopa—Agranulocytosis—Docetaxel—melanoma	0.00174	0.00238	CcSEcCtD
Carbidopa—Hypotension—Carmustine—melanoma	0.00173	0.00236	CcSEcCtD
Carbidopa—Hyperhidrosis—Temozolomide—melanoma	0.00173	0.00236	CcSEcCtD
Carbidopa—Decreased appetite—Dactinomycin—melanoma	0.00172	0.00235	CcSEcCtD
Carbidopa—Fatigue—Dactinomycin—melanoma	0.0017	0.00233	CcSEcCtD
Carbidopa—Anorexia—Temozolomide—melanoma	0.0017	0.00233	CcSEcCtD
Carbidopa—Pain—Dactinomycin—melanoma	0.00169	0.00231	CcSEcCtD
Carbidopa—Urticaria—Bleomycin—melanoma	0.00168	0.0023	CcSEcCtD
Carbidopa—Haemoglobin—Docetaxel—melanoma	0.00168	0.0023	CcSEcCtD
Carbidopa—Rhinitis—Docetaxel—melanoma	0.00167	0.00229	CcSEcCtD
Carbidopa—Body temperature increased—Bleomycin—melanoma	0.00167	0.00229	CcSEcCtD
Carbidopa—Haemorrhage—Docetaxel—melanoma	0.00167	0.00228	CcSEcCtD
Carbidopa—Insomnia—Carmustine—melanoma	0.00167	0.00228	CcSEcCtD
Carbidopa—Hypoaesthesia—Docetaxel—melanoma	0.00166	0.00227	CcSEcCtD
Carbidopa—Paraesthesia—Carmustine—melanoma	0.00166	0.00227	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—HIF1A—melanoma	0.00166	0.00661	CbGpPWpGaD
Carbidopa—Urinary tract disorder—Docetaxel—melanoma	0.00165	0.00226	CcSEcCtD
Carbidopa—Dyspnoea—Carmustine—melanoma	0.00165	0.00225	CcSEcCtD
Carbidopa—Somnolence—Carmustine—melanoma	0.00164	0.00225	CcSEcCtD
Carbidopa—Urethral disorder—Docetaxel—melanoma	0.00164	0.00224	CcSEcCtD
Carbidopa—Feeling abnormal—Dactinomycin—melanoma	0.00163	0.00222	CcSEcCtD
Carbidopa—Insomnia—Temozolomide—melanoma	0.00161	0.00221	CcSEcCtD
Carbidopa—Gastrointestinal pain—Dactinomycin—melanoma	0.00161	0.00221	CcSEcCtD
Carbidopa—Decreased appetite—Carmustine—melanoma	0.00161	0.0022	CcSEcCtD
Carbidopa—Paraesthesia—Temozolomide—melanoma	0.0016	0.00219	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Carmustine—melanoma	0.00159	0.00218	CcSEcCtD
Carbidopa—Dyspnoea—Temozolomide—melanoma	0.00159	0.00218	CcSEcCtD
Carbidopa—Somnolence—Temozolomide—melanoma	0.00159	0.00217	CcSEcCtD
Carbidopa—Pain—Carmustine—melanoma	0.00158	0.00216	CcSEcCtD
Carbidopa—Constipation—Carmustine—melanoma	0.00158	0.00216	CcSEcCtD
Carbidopa—Dyspepsia—Temozolomide—melanoma	0.00157	0.00215	CcSEcCtD
Carbidopa—Abdominal pain—Dactinomycin—melanoma	0.00156	0.00213	CcSEcCtD
Carbidopa—Body temperature increased—Dactinomycin—melanoma	0.00156	0.00213	CcSEcCtD
Carbidopa—Hypersensitivity—Bleomycin—melanoma	0.00156	0.00213	CcSEcCtD
Carbidopa—Decreased appetite—Temozolomide—melanoma	0.00155	0.00212	CcSEcCtD
Carbidopa—Flushing—Docetaxel—melanoma	0.00155	0.00212	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Temozolomide—melanoma	0.00154	0.00211	CcSEcCtD
Carbidopa—Fatigue—Temozolomide—melanoma	0.00154	0.0021	CcSEcCtD
Carbidopa—Pain—Temozolomide—melanoma	0.00153	0.00209	CcSEcCtD
Carbidopa—Constipation—Temozolomide—melanoma	0.00153	0.00209	CcSEcCtD
Carbidopa—Feeling abnormal—Carmustine—melanoma	0.00152	0.00208	CcSEcCtD
Carbidopa—Asthenia—Bleomycin—melanoma	0.00152	0.00208	CcSEcCtD
Carbidopa—DDC—Metabolism—ACER3—melanoma	0.00152	0.00605	CbGpPWpGaD
Carbidopa—Gastrointestinal pain—Carmustine—melanoma	0.00151	0.00207	CcSEcCtD
Carbidopa—Pruritus—Bleomycin—melanoma	0.0015	0.00205	CcSEcCtD
Carbidopa—Alopecia—Docetaxel—melanoma	0.00148	0.00202	CcSEcCtD
Carbidopa—Feeling abnormal—Temozolomide—melanoma	0.00147	0.00201	CcSEcCtD
Carbidopa—Mental disorder—Docetaxel—melanoma	0.00146	0.002	CcSEcCtD
Carbidopa—Abdominal pain—Carmustine—melanoma	0.00146	0.002	CcSEcCtD
Carbidopa—Body temperature increased—Carmustine—melanoma	0.00146	0.002	CcSEcCtD
Carbidopa—Gastrointestinal pain—Temozolomide—melanoma	0.00146	0.002	CcSEcCtD
Carbidopa—Hypersensitivity—Dactinomycin—melanoma	0.00145	0.00199	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—FAS—melanoma	0.00144	0.00574	CbGpPWpGaD
Carbidopa—Dysgeusia—Docetaxel—melanoma	0.00142	0.00195	CcSEcCtD
Carbidopa—Urticaria—Temozolomide—melanoma	0.00142	0.00194	CcSEcCtD
Carbidopa—Asthenia—Dactinomycin—melanoma	0.00142	0.00194	CcSEcCtD
Carbidopa—Body temperature increased—Temozolomide—melanoma	0.00141	0.00193	CcSEcCtD
Carbidopa—Abdominal pain—Temozolomide—melanoma	0.00141	0.00193	CcSEcCtD
Carbidopa—Back pain—Docetaxel—melanoma	0.00141	0.00192	CcSEcCtD
Carbidopa—Muscle spasms—Docetaxel—melanoma	0.0014	0.00191	CcSEcCtD
Carbidopa—DDC—Metabolism—UGT2B10—melanoma	0.00139	0.00553	CbGpPWpGaD
Carbidopa—Hypersensitivity—Carmustine—melanoma	0.00136	0.00186	CcSEcCtD
Carbidopa—Diarrhoea—Dactinomycin—melanoma	0.00135	0.00185	CcSEcCtD
Carbidopa—Vomiting—Bleomycin—melanoma	0.00135	0.00184	CcSEcCtD
Carbidopa—Anaemia—Docetaxel—melanoma	0.00134	0.00184	CcSEcCtD
Carbidopa—Rash—Bleomycin—melanoma	0.00133	0.00182	CcSEcCtD
Carbidopa—Dermatitis—Bleomycin—melanoma	0.00133	0.00182	CcSEcCtD
Carbidopa—Asthenia—Carmustine—melanoma	0.00133	0.00181	CcSEcCtD
Carbidopa—Hypersensitivity—Temozolomide—melanoma	0.00132	0.0018	CcSEcCtD
Carbidopa—Syncope—Docetaxel—melanoma	0.0013	0.00178	CcSEcCtD
Carbidopa—Leukopenia—Docetaxel—melanoma	0.0013	0.00178	CcSEcCtD
Carbidopa—DDC—Metabolism—HS3ST5—melanoma	0.00129	0.00514	CbGpPWpGaD
Carbidopa—Palpitations—Docetaxel—melanoma	0.00129	0.00176	CcSEcCtD
Carbidopa—Asthenia—Temozolomide—melanoma	0.00128	0.00175	CcSEcCtD
Carbidopa—Loss of consciousness—Docetaxel—melanoma	0.00128	0.00175	CcSEcCtD
Carbidopa—Cough—Docetaxel—melanoma	0.00127	0.00174	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—CDK4—melanoma	0.00127	0.00505	CbGpPWpGaD
Carbidopa—Diarrhoea—Carmustine—melanoma	0.00126	0.00173	CcSEcCtD
Carbidopa—Pruritus—Temozolomide—melanoma	0.00126	0.00173	CcSEcCtD
Carbidopa—Convulsion—Docetaxel—melanoma	0.00126	0.00172	CcSEcCtD
Carbidopa—Nausea—Bleomycin—melanoma	0.00126	0.00172	CcSEcCtD
Carbidopa—Hypertension—Docetaxel—melanoma	0.00126	0.00172	CcSEcCtD
Carbidopa—Vomiting—Dactinomycin—melanoma	0.00125	0.00172	CcSEcCtD
Carbidopa—Rash—Dactinomycin—melanoma	0.00124	0.0017	CcSEcCtD
Carbidopa—Chest pain—Docetaxel—melanoma	0.00124	0.00169	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—NOS2—melanoma	0.00123	0.00491	CbGpPWpGaD
Carbidopa—Dizziness—Carmustine—melanoma	0.00122	0.00167	CcSEcCtD
Carbidopa—Diarrhoea—Temozolomide—melanoma	0.00122	0.00167	CcSEcCtD
Carbidopa—Dry mouth—Docetaxel—melanoma	0.00121	0.00166	CcSEcCtD
Carbidopa—Confusional state—Docetaxel—melanoma	0.0012	0.00164	CcSEcCtD
Carbidopa—Oedema—Docetaxel—melanoma	0.00119	0.00162	CcSEcCtD
Carbidopa—Dizziness—Temozolomide—melanoma	0.00118	0.00161	CcSEcCtD
Carbidopa—Infection—Docetaxel—melanoma	0.00118	0.00161	CcSEcCtD
Carbidopa—Vomiting—Carmustine—melanoma	0.00117	0.00161	CcSEcCtD
Carbidopa—Nausea—Dactinomycin—melanoma	0.00117	0.0016	CcSEcCtD
Carbidopa—Shock—Docetaxel—melanoma	0.00117	0.0016	CcSEcCtD
Carbidopa—Rash—Carmustine—melanoma	0.00116	0.00159	CcSEcCtD
Carbidopa—Dermatitis—Carmustine—melanoma	0.00116	0.00159	CcSEcCtD
Carbidopa—Thrombocytopenia—Docetaxel—melanoma	0.00116	0.00159	CcSEcCtD
Carbidopa—Headache—Carmustine—melanoma	0.00116	0.00158	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—PPARG—melanoma	0.00115	0.00459	CbGpPWpGaD
Carbidopa—Vomiting—Temozolomide—melanoma	0.00113	0.00155	CcSEcCtD
Carbidopa—Anorexia—Docetaxel—melanoma	0.00113	0.00155	CcSEcCtD
Carbidopa—Rash—Temozolomide—melanoma	0.00113	0.00154	CcSEcCtD
Carbidopa—Dermatitis—Temozolomide—melanoma	0.00112	0.00154	CcSEcCtD
Carbidopa—Headache—Temozolomide—melanoma	0.00112	0.00153	CcSEcCtD
Carbidopa—Hypotension—Docetaxel—melanoma	0.00111	0.00152	CcSEcCtD
Carbidopa—Nausea—Carmustine—melanoma	0.0011	0.0015	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—CXCL8—melanoma	0.00108	0.00429	CbGpPWpGaD
Carbidopa—Insomnia—Docetaxel—melanoma	0.00107	0.00147	CcSEcCtD
Carbidopa—Paraesthesia—Docetaxel—melanoma	0.00107	0.00146	CcSEcCtD
Carbidopa—Nausea—Temozolomide—melanoma	0.00106	0.00145	CcSEcCtD
Carbidopa—Dyspnoea—Docetaxel—melanoma	0.00106	0.00145	CcSEcCtD
Carbidopa—Somnolence—Docetaxel—melanoma	0.00106	0.00144	CcSEcCtD
Carbidopa—Dyspepsia—Docetaxel—melanoma	0.00104	0.00143	CcSEcCtD
Carbidopa—Decreased appetite—Docetaxel—melanoma	0.00103	0.00141	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—CASP3—melanoma	0.00103	0.0041	CbGpPWpGaD
Carbidopa—Gastrointestinal disorder—Docetaxel—melanoma	0.00102	0.0014	CcSEcCtD
Carbidopa—Fatigue—Docetaxel—melanoma	0.00102	0.0014	CcSEcCtD
Carbidopa—Constipation—Docetaxel—melanoma	0.00102	0.00139	CcSEcCtD
Carbidopa—Pain—Docetaxel—melanoma	0.00102	0.00139	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000993	0.00396	CbGpPWpGaD
Carbidopa—Feeling abnormal—Docetaxel—melanoma	0.000978	0.00134	CcSEcCtD
Carbidopa—DDC—Metabolism—PLCB4—melanoma	0.000978	0.0039	CbGpPWpGaD
Carbidopa—Gastrointestinal pain—Docetaxel—melanoma	0.000971	0.00133	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000963	0.00384	CbGpPWpGaD
Carbidopa—Abdominal pain—Docetaxel—melanoma	0.000938	0.00128	CcSEcCtD
Carbidopa—Body temperature increased—Docetaxel—melanoma	0.000938	0.00128	CcSEcCtD
Carbidopa—DDC—Metabolism—SLC6A11—melanoma	0.000919	0.00366	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIP4K2A—melanoma	0.000919	0.00366	CbGpPWpGaD
Carbidopa—DDC—Metabolism—MTAP—melanoma	0.000894	0.00356	CbGpPWpGaD
Carbidopa—Hypersensitivity—Docetaxel—melanoma	0.000875	0.0012	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000874	0.00348	CbGpPWpGaD
Carbidopa—Asthenia—Docetaxel—melanoma	0.000852	0.00116	CcSEcCtD
Carbidopa—Pruritus—Docetaxel—melanoma	0.00084	0.00115	CcSEcCtD
Carbidopa—Diarrhoea—Docetaxel—melanoma	0.000812	0.00111	CcSEcCtD
Carbidopa—DDC—Metabolism—PHGDH—melanoma	0.000797	0.00318	CbGpPWpGaD
Carbidopa—DDC—Metabolism—LUM—melanoma	0.000797	0.00318	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PTEN—melanoma	0.00079	0.00315	CbGpPWpGaD
Carbidopa—Dizziness—Docetaxel—melanoma	0.000785	0.00107	CcSEcCtD
Carbidopa—DDC—Metabolism—HPSE—melanoma	0.000782	0.00311	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CUBN—melanoma	0.000767	0.00306	CbGpPWpGaD
Carbidopa—Vomiting—Docetaxel—melanoma	0.000755	0.00103	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—TNF—melanoma	0.000749	0.00298	CbGpPWpGaD
Carbidopa—Rash—Docetaxel—melanoma	0.000748	0.00102	CcSEcCtD
Carbidopa—Dermatitis—Docetaxel—melanoma	0.000748	0.00102	CcSEcCtD
Carbidopa—Headache—Docetaxel—melanoma	0.000744	0.00102	CcSEcCtD
Carbidopa—DDC—Metabolism—SDHD—melanoma	0.000741	0.00295	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CSPG4—melanoma	0.000741	0.00295	CbGpPWpGaD
Carbidopa—DDC—Metabolism—BSG—melanoma	0.000741	0.00295	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GPAM—melanoma	0.000718	0.00286	CbGpPWpGaD
Carbidopa—Nausea—Docetaxel—melanoma	0.000705	0.000964	CcSEcCtD
Carbidopa—DDC—Metabolism—PLA2G6—melanoma	0.00061	0.00243	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL6—melanoma	0.000604	0.00241	CbGpPWpGaD
Carbidopa—DDC—Metabolism—VCAN—melanoma	0.000548	0.00218	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TP53—melanoma	0.000539	0.00215	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—IL6—melanoma	0.000493	0.00197	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP17A1—melanoma	0.000462	0.00184	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GNA11—melanoma	0.000437	0.00174	CbGpPWpGaD
Carbidopa—DDC—Metabolism—FASN—melanoma	0.000427	0.0017	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SLC5A5—melanoma	0.00042	0.00168	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CD44—melanoma	0.000406	0.00162	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GNAQ—melanoma	0.000406	0.00162	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP1B1—melanoma	0.000389	0.00155	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ABCB1—melanoma	0.000321	0.00128	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PRKCA—melanoma	0.000295	0.00118	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ERCC2—melanoma	0.000293	0.00117	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CG—melanoma	0.000231	0.000921	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PPARG—melanoma	0.000223	0.000889	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CD—melanoma	0.000203	0.000809	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ALB—melanoma	0.000201	0.000799	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CB—melanoma	0.000177	0.000706	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTGS2—melanoma	0.000175	0.000699	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTEN—melanoma	0.000153	0.00061	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CA—melanoma	0.000108	0.00043	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AKT1—melanoma	8.82e-05	0.000351	CbGpPWpGaD
